A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU

Clinical trial NCT07552012 · RECRUITING

Trial details

NCT number: NCT07552012
Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Active Non-anterior, Non-infectious Uveitis

Start date: 2026-01-29
Primary completion: 2027-02-28
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.